How much funding has BioRender raised?

BioRender has raised $17.1M in total funding, most recently a Series A round.

Who are BioRender's investors?

BioRender's investors include Y Combinator Continuity Fund, Dimension Capital, Sequoia Capital, FundersClub, Refactor Capital.

Where is BioRender headquartered?

BioRender is headquartered in Toronto, Canada.

What industry is BioRender in?

BioRender operates in Design Tools, SaaS.

How many employees does BioRender have?

BioRender has 201-500 employees.

BioRender

'Figma/Canva for scientists’

Toronto, Canada · Founded 2018 · $17.1M raised

Design Tools

SaaS

YC W18

Headquarters: Toronto
Employees: 201–500
Founded: 2018
Business Model: B2B

Website: biorender.com
Total Funding: $17.1M
Last Round: $17.0M Series AApr 2023
Rounds: 2

About

You can think of BioRender as the ‘Figma/Canva for scientists’, with a suite of web-based graphics communication products to empower scientists to create beautiful scientific visuals and presentations with ease. BioRender is the world’s first tool to help scientists create and share beautiful, professional scientific figures. Our mission is to accelerate the world’s ability to learn, discover and communicate science. We are passionate about democratizing science communication in order to accelerate scientific discovery and understanding.

Summary

BioRender is a Design Tools company based in Toronto, Canada, founded in 2018. It has raised $17.1M in total across 2 rounds, most recently a $17.0M Series A round in Apr 2023. Investors include Y Combinator Continuity Fund, Dimension Capital and Sequoia Capital.

LinkedIn X (Twitter)